Lonza upgrades clinical manufacturing services at Bend site to include bottling and labeling capabilities
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
Natco Pharma intends to defend the matter accordingly
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
Subscribe To Our Newsletter & Stay Updated